Company Filing History:
5 out of 2,613 
1 out of 321 
Years Active: 2011-2019
Title: Yong-mahn Han: Innovator in Stem Cell Research
Introduction
Yong-mahn Han is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of stem cell research, particularly in the development of induced pluripotent stem cell models for various diseases. With a total of 6 patents, his work has the potential to advance therapeutic strategies for complex medical conditions.
Latest Patents
One of his latest patents is an "Induced pluripotent stem cell model for Fabry disease and use thereof." This invention relates to a model that aids in the study of Fabry disease development and the screening of therapeutic agents. The model utilizes fibroblasts from Fabry disease patients to create induced pluripotent stem cells (iPSCs) that exhibit reduced GLA protein expression, leading to the accumulation of globotriaosylceramide (Gb3). The differentiation of vascular cells from these iPSCs has shown promise in analyzing the disease's outbreak mechanism and testing potential treatments.
Another significant patent is the "Induced pluripotent stem cell model for cardiofaciocutaneous syndrome and uses thereof." This invention focuses on a model that helps analyze neural development in patients with cardiofaciocutaneous syndrome. The model was developed from fibroblasts of a CFC syndrome patient and demonstrated the ability to differentiate into neurons when treated with specific inhibitors, providing insights into neural development challenges associated with the syndrome.
Career Highlights
Yong-mahn Han has worked with esteemed institutions such as the Korea Advanced Institute of Science and Technology and the Korea Research Institute of Bioscience and Biotechnology. His research has been pivotal in advancing the understanding of stem cell applications in treating genetic disorders.
Collaborations
Some of his notable coworkers include Sang-Wook Park and Kyu-Min Han. Their collaborative efforts have contributed to the success of various research projects and innovations in the field.
Conclusion
Yong-mahn Han's innovative work in stem cell research has the potential to transform therapeutic approaches for diseases like Fabry disease and cardiofaciocutaneous syndrome. His contributions are invaluable to the scientific community and hold promise for future medical advancements.